8DA-31186-61798
3 vaccinations
2 coded responses
36 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 430 / OH
- Registered
- 2021-03-31
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-31
Registered in v-safe
-
2021-03-31
Dose 1 — Pfizer-BioNTech
- 2021-03-31
- 2021-04-01
- 2021-04-02
- 2021-04-03
- 2021-04-04
- 2021-04-05
- 2021-04-06
- 2021-04-07
- 2021-04-16
- 2021-04-21
-
2021-04-23
Dose 2 — Pfizer-BioNTech
-
2021-04-28
Survey response — days 1–6 daily, dose 2MedDRA: Adverse reaction — Feeling: Good · Site: Pain · Chills, Muscle or body aches, Fatigue or tirednessFree text: These symptoms were on April 24MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-29
- 2021-04-30
- 2021-05-07
- 2021-05-14
- 2021-05-21
- 2021-05-28
- 2021-06-04
- 2021-07-23
- 2021-10-22
-
2022-01-06
Dose 3 — Pfizer-BioNTech
- 2022-01-06
-
2022-01-07
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2022-01-08
- 2022-01-09
- 2022-01-10
- 2022-01-11
- 2022-01-12
- 2022-01-13
- 2022-01-20
- 2022-01-27
- 2022-02-03
-
2022-02-10
Survey response — day 35, dose 3MedDRA: Delivery, Haemorrhage, Hospitalisation, Rest regimen, Syncope — Feeling: Good · Be unable to work or attend school, Get care from a doctor or other healthcare professionalFree text: Symptoms: Had a baby. Hemmoraged. Fainting spells after. Sent home with iron pills and rest until body recuperates · Healthcare visit (other): Extra time at hospital after having babyMedDRA releases: 2024-11 · check-in free text available
-
2022-02-10
Report sent to call center — day 35, dose 3Be unable to work or attend school · Get care from a doctor or other healthcare professional1 call case(s)
- 2022-02-14
- 2022-02-17
- 2022-04-07
- 2022-07-07
- 2023-01-06
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-31 | Pfizer-BioNTech | |
| 2 | 2021-04-23 | Pfizer-BioNTech | |
| 3 | 2022-01-06 | Pfizer-BioNTech | No |
Call center
1 call center case
1 unsuccessful
Free text
Release 8 — days 1–6 daily, dose 2
Systemic reaction (other): These symptoms were on April 24
Release 11 — day 35, dose 3
Symptoms: Had a baby. Hemmoraged. Fainting spells after. Sent home with iron pills and rest until body recuperates
Healthcare visit (other): Extra time at hospital after having baby
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Delivery | · | · | ✓ |
| HCVO | Hospitalisation | · | · | ✓ |
| SD | Delivery | · | · | ✓ |
| SD | Haemorrhage | · | · | ✓ |
| SD | Rest regimen | · | · | ✓ |
| SD | Syncope | · | · | ✓ |
| SRO | Adverse reaction | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release